Neovascular Retinal Disease: Examining Emerging Trends in Treatment

Neovascular Retinal Disease: Examining Emerging Trends in Treatment

The integration of intravitreal anti-vascular endothelial growth factor (a…

Expiration Date: 9/11/2020

Max Credits: 0.75

View Activity

Intravitreal Interventions: Volume 8, Number 2

Intravitreal Interventions: Volume 8, Number 2

Unprecedented growth has occurred over the past few years in the diagnosis…

Expiration Date: 8/29/2020

Max Credits: 1.25

View Activity

Neovascular Age-related Macular Degeneration: Emerging Therapies With an EYE On Treatment Frequency

Neovascular Age-related Macular Degeneration: Emerging Therapies With an EYE On Treatment Frequency

The treatment of neovascular age-related macular degeneration (nAMD) has b…

Expiration Date: 8/27/2020

Max Credits: 1.25

View Activity

Transitioning Treatment in Diabetic Retinopathy

Transitioning Treatment in Diabetic Retinopathy

Intravitreal therapy has rapidly evolved to become a mainstay of treatment…

Expiration Date: 7/18/2020

Max Credits: 0.75

View Activity

Intravitreal Interventions: Volume 8, Number 1

Intravitreal Interventions: Volume 8, Number 1

Unprecedented growth has occurred over the past few years in the diagnosis…

Expiration Date: 6/27/2020

Max Credits: 1

View Activity

Diabetic Macular Edema: The Multimodal Movement Toward Real-Life Management

Diabetic Macular Edema: The Multimodal Movement Toward Real-Life Management

In the anti-vascular endothelial growth factor (VEGF) era, steroids, laser…

Expiration Date: 5/19/2020

Max Credits: 0

View Activity

RetinaCME ® Presents Updates from Vancouver: Best of Ophthalmology Research - Transitioning Treatment in Diabetic Retinopathy

RetinaCME® Presents Updates from Vancouver: Best of Ophthalmology Research - Transitioning Treatment in Diabetic Retinopathy

Diabetic retinopathy (DR) continues to be a leading cause of blindness wor…

Expiration Date: 5/8/2020

Max Credits: 0

View Activity

RetinaCME ® Presents Updates from Vancouver: Best of Ophthalmology Research on Improving Outcomes With New Treatment Options for Neovascular Retinal Diseases

RetinaCME® Presents Updates from Vancouver: Best of Ophthalmology Research on Improving Outcomes With New Treatment Options for Neovascular Retinal Diseases

The integration of intravitreal anti-vascular endothelial growth factor (a…

Expiration Date: 5/8/2020

Max Credits: 0

View Activity

Improving the Burden of Treatment for Age-related Macular Degeneration through Advances in Delivery

Improving the Burden of Treatment for Age-related Macular Degeneration through Advances in Delivery

Intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy h…

Expiration Date: 5/2/2020

Max Credits: 0

View Activity

Thinking Outside the Box When Treating Noninfectious Uveitis

Thinking Outside the Box When Treating Noninfectious Uveitis

Noninfectious uveitis is a leading cause of preventable blindness worldwid…

Expiration Date: 4/11/2021

Max Credits: 0.5

View Activity